US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 24, 2016 (10 years ago)

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

What was recalled

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054

Recalling firm
Sandoz Inc
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0133-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Scopolamine recalls

See all